Human Endogenous Retroviruses as Novel Therapeutic Targets in Neurodegenerative Disorders
Human Endogenous Retroviruses comprise approximately 8% of the human genome, serving as fragments of ancient retroviral infections. Although they are generally maintained in a silenced state by robust epigenetic mechanisms, specific HERV groups, particularly HERV-W and HERV-K, can become derepressed...
Saved in:
| Main Authors: | Elena Rita Simula, Seyedesomaye Jasemi, Davide Cossu, Milena Fais, Ilaria Cossu, Vanna Chessa, Mattia Canu, Leonardo Antonio Sechi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/13/4/415 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring novel experimental treatments for major neurodegenerative disorders
by: Xunming Ji, et al.
Published: (2023-12-01) -
Insulin and Metformin are Associated With Reduced Risk of Amyotrophic Lateral Sclerosis
by: Steven Lehrer, et al.
Published: (2025-06-01) -
The landscape of non-reference SINE-VNTR-Alus in amyotrophic lateral sclerosis
by: Abigail L. Pfaff, et al.
Published: (2025-05-01) -
Advancements in extracellular vesicle therapy for neurodegenerative diseases
by: Ningyun Hu, et al.
Published: (2025-05-01) -
Optical coherence tomography in neurodegenerative disorders
by: Leonardo Provetti CUNHA, et al.
Published: (2022-03-01)